Ridge Biotechnologies launches with $25M to drive AI-enabled precision drug design

READ MORE  ►

Prellis Biologics enters multi-target collaboration with Lilly to advance human antibody therapeutics

READ MORE  ►

RevOpsis Therapeutics receives investment from ExSight Ventures to advance treatments for eye diseases

READ MORE  ►

Heritable Agriculture & Syngenta enter partnership for AI-optimized crop portfolios

READ MORE  ►

Submissions are now open for the 2025 AbbVie Golden Ticket Competition

READ MORE  ►

Founders at Work: Lume Health

The Future of Wearables: Continuous Hormone Monitoring

October 8th @ 12-1pm
135 Mississippi St, San Francisco

The case for continuous hormone monitoring has never been stronger. Modern life is disrupting our finely tuned hormonal balance, driving fatigue, poor sleep, and long-term health issues. Lume Health is developing the first needle-free continuous hormone monitor using aptamer biosensor technology to deliver real-time insights that drive meaningful behavior change.

Please join us for Founders at Work featuring the Lume Health team and learn more about what they are building!

REGISTER  ►

Revvity Meet & Greet - Explore Oncology Solutions

October 8th @ 3-5pm
1030 Brittan Ave, San Carlos

We’re welcoming our friends at Revvity for an open house and meet-and-greet highlighting oncology solutions and offerings across the life sciences ecosystem. Enjoy lively networking over bites and drinks. Breast Cancer Awareness Month: Revvity will donate $5 per attendee to the Breast Cancer Foundation.

REGISTER  ►

New QIAGEN Products Launching at MBC BioLabs!

The MBC BioLabs core lab is growing! Join us to learn about two exciting new instruments that are coming to the MBC BioLabs core lab:

October 14th @ 12-1pm
1030 Brittan Ave, San Carlos

QIAxcel: capillary-electrophoresis with ready-to-run gel cartridges to eliminate tedious gel prep. The instrument will be placed in the 1030 core lab.

REGISTER ►

October 15th @ 12-1pm
953 Indiana St, San Francisco

EZ2 Connect: benchtop instrument for automated nucleic acid isolation from up to 24 samples in parallel using sealed, prefilled cartridges.

REGISTER ►

SPT Labtech Lunch & Learn

October 22nd @ 12-1pm
1030 Brittan Ave, San Carlos

Join our partners at SPT Labtech for an informational session over lunch focused on automating RNA and DNA Library Prep Kits provided by Watchmaker Genomics. Technical representatives from both SPT Labtech and Watchmaker Genomics will be available for questions. Lunch will be provided for those who register in advance.

REGISTER ►

Homogenization Made Easy: Demo & Lunch with Revvity

October 28th @ 12-1pm
1030 Brittan Ave, San Carlos

Join Kate Hofbauer, Revvity’s homogenization specialist, for a hands-on demo of the Omni Bead Ruptor Elite. Bring tissue, microbial, or cell samples for on-site processing, get expert tips on lysis and extraction workflows, and enjoy lunch — plus a free bead kit & demo promotion.

REGISTER ►

OUTbio Bay Area Mixer

October 29th @ 5:30-7:30pm
1030 Brittan Ave, San Carlos

Join us for an evening of networking and collaboration hosted by Deciduous Therapeutics, MBC BioLabs and Thermo Fisher Scientific.

This event offers a fantastic opportunity to connect with other LGBTQIA+ professionals in the biotech and life sciences industry.

REGISTER ►

MBC BioLabs ClimateTech & AgTech Innovation Forum

November 13th @ 3:30-7:30pm
1030 Brittan Ave, San Carlos

We’re excited to host our fourth Innovation Forum, celebrating breakthrough climate and ag tech startups. This gathering brings together the ecosystem of climate founders, leaders, and investors who are driving planetary health solutions. The evening is designed to bring our community together, share ideas, and spark connections toward a sustainable future.

This will be an invitation-only event with a curated audience of investors and fellow MBC BioLabs founders in the climate and ag tech spaces.  

LEARN MORE ►

Therna Biosciences has built a biology-guided AI platform that integrates deep RNA biology with generative AI to design programmable RNA medicines across modalities like mRNA, ASOs, and siRNA. It explores RNA sequence space beyond natural limits to engineer RNA molecules with enhanced translation efficiency, stability, immune evasion, and tissue specificity. Therna's “lab‑in‑the‑loop” methodology incorporates proprietary biological data sets at scale into the AI platform and enables rapid, iterative optimization of RNA sequences, accelerating development of fit-to-purpose RNA‑based medicines.

We are thrilled to welcome CEO Nazli Azimi, Director of Translational Research Kian Yousefi and Director of mRNA Research Timo Hagen to our wonderful community at 135 Mississippi St, San Francisco!

LEARN MORE  ►